First New York Securities’s Ambit Biosciences Corp AMBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-3,000
Closed -$46.2K 652
2014
Q3
$46.2K Buy
+3,000
New +$20.6K 0.03% 265

First New York Securities's AMBI Position: Q4 2014 in Review

First New York Securities sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 3,000 shares — an estimated $46.2K sold.

First New York Securities first reported a position in AMBI in Q3 2014 and held it in 1 quarter. The position peaked at $46.2K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • First New York Securities reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • First New York Securities sold 3,000 Ambit Biosciences Corp shares in Q4 2014, an estimated $46.2K.
  • First New York Securities first reported a position in Ambit Biosciences Corp in Q3 2014 and held it in 1 quarter.
  • First New York Securities's Ambit Biosciences Corp position peaked at $46.2K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on First New York Securities's 13F filing for Q4 2014, filed 9 Jan 2015.